Peer-reviewedCC BY 4.0Frontiers in Pharmacology
Pharmaceutical value under uncertainty: a theory of reproducible therapeutic surplus
Related
- Computational surveillance of Colombian public pharmaceutical procurement using public administrative data: A reproducible analysis of a closed 2020–2025 cohort
- Zinc in Inflammatory Bowel Disease: Biological Functions, Clinical Associations and Therapeutic Uncertainty
- Information theory and diagnostic reasoning in primary care: a framework for navigating uncertainty.
- Mishel’s Theory of Uncertainty in Illness in Support of Clinical Reasoning and Nursing Care Practices
- Mishel theory-based perioperative nursing after trabeculectomy for primary glaucoma: effects on illness uncertainty, self-management, and quality of life
BibTeX
@article{condorelli2026pharmaceutical,
title = {{Pharmaceutical value under uncertainty: a theory of reproducible therapeutic surplus}},
author = {Guido Attilio Condorelli and Stefano Capri and Oriol Solà‐Morales and Filippo Drago},
journal = {Frontiers in Pharmacology},
year = {2026},
month = nov,
doi = {10.3389/fphar.2026.2041618},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.2041618},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pharmaceutical value under uncertainty: a theory of reproducible therapeutic surplus
AU - Guido Attilio Condorelli
AU - Stefano Capri
AU - Oriol Solà‐Morales
AU - Filippo Drago
PY - 2026
DA - 2026/11/05
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.2041618
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.2041618
SN - 1663-9812
ER -